
    
      Interventions will be carried out with intravitreal injections in patients with formal
      indications of diabetic macular edema treatment previously assessed with complete eye
      examination in Goiania Eye Institute(Instituto de Olhos de Goi√¢nia)

      Patients will be divided into four groups:

        -  In the first group will be held three applications of intravitreal ranibizumab 0.1 ml,
           with one application every month and follow up with Optical Coherence Tomography on days
           1, 3, 5, 10 and 30 following the application.

        -  In the second group will be held three applications of Intravitreal Aflibercept 0.1 ml,
           with one application each month followed by monitoring with Optical Coherence Tomography
           on days 1, 3, 5, 10 and 30 subsequent

        -  The third group will be held two applications of Ranibizumab 0.1 ml interspersed with
           one application of Aflibercept 0.1 ml in the second month and subsequent evaluation with
           Optical Coherence Tomography on days 1, 3, 5, 10 and 30.

        -  In the fourth group will be held two applications of 0.1 ml Aflibercept interspersed
           with one application of Ranibizumab 0.1 ml in the second month and subsequent evaluation
           with Optical Coherence Tomography on days 1, 3, 5, 10 and 30.
    
  